Karyopharm Therapeutics Inc. Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Karyopharm Therapeutics Inc. Operating Margin for the quarter ending June 30, 2024 was -89.9 %, a 4.85% decline year-over-year.
  • Karyopharm Therapeutics Inc. annual Operating Margin for 2023 was -88.7 %, a 2.02% increase from 2022.
  • Karyopharm Therapeutics Inc. annual Operating Margin for 2022 was -90.5 %, a 93.3% decline from 2021.
  • Karyopharm Therapeutics Inc. annual Operating Margin for 2021 was -46.8 %, a 70.5% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -88.7 +1.83 +2.02% Jan 1, 2023 Dec 31, 2023
2022 -90.5 -43.7 -93.3% Jan 1, 2022 Dec 31, 2022
2021 -46.8 +112 +70.5% Jan 1, 2021 Dec 31, 2021
2020 -159 +304 +65.6% Jan 1, 2020 Dec 31, 2020
2019 -463 +130 +21.9% Jan 1, 2019 Dec 31, 2019
2018 -593 +7.54K +92.7% Jan 1, 2018 Dec 31, 2018
2017 -8.13K +63.8K +88.7% Jan 1, 2017 Dec 31, 2017
2016 -71.9K Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.